Acquisition to Accelerate Development of Research and Therapeutic Products ALAMEDA, Calif.–BioTime, Inc. (NYSE Amex: BTIM), a biotechnology company that develops and markets products in the field of human stem cells and regenerative medicine, today announced that it has completed its acquisition of the Singapore company ES Cell International Pte Ltd (“ESI”). Established in 2000, ESI […]

ADELAIDE, Australia–TGR BioSciences announces expansion of the extremely successful and proven ‘No-wash’ SureFire® portfolio by addition of 9 new cell pathway analysis kits for measurement of phospho-proteins. The SureFire® technology is an exquisitely sensitive assay system which utilizes PerkinElmer’s ALPHA/Amplified Luminescent Proximity Homogeneous Assay detection chemistry. The SureFire® technology is widely employed by many of […]

Advanced Genealogical Test Uses Axiom Technology from Affymetrix to Match Family Members Across All Ancestral Lines HOUSTON & SANTA CLARA, Calif.–Family Tree DNA, the first and largest genealogical DNA testing company, today announced the launch of the Family Finder DNA test for connecting family members across all ancestral lines. The test utilizes Affymetrix’ (NASDAQ:AFFX) recently […]

CORALVILLE, Iowa — — Vivakor, Inc. /quotes/comstock/11k!vivk (VIVK 0.10, -0.04, -29.08%) announced today that it has received a reseller offer agreement from VWR LLC, a multi-billion dollar global laboratory supply and distribution company, for Vivakor’s VivaThermic Vials. Vivakor’s VivaThermic vials improve cryopreservation of sensitive cell types such as human stem cells. Vivakor ‘s Chief Executive […]

Takara Bio Inc. (Shiga, Japan) today announced that it has granted QIAGEN GmbH (Hilden, Germany) a worldwide non-exclusive license to make, use and sell LA-PCR related products under the patents covering the LA-PCR technology, which Takara Bio owns. Including QIAGEN, the company has twenty four (24) licensees of its LA-PCR technology worldwide. Financial terms of […]

Emily Winn-Deen as Vice President, Diagnostics Development SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced the appointments of Elizabeth Brady as vice president, Global Supply Chain, and Emily S. Winn-Deen, Ph.D., as vice president, Diagnostics Development. “Elizabeth has an outstanding background as a senior leader with extensive global experience in supply chain management spanning the electronics and […]

Rapidly becoming the industry standard for analyzing chemical imaging data, ISys 5.0 from Malvern Instruments is available for license on a wide range of analytical systems. Providing a single platform that supports the import and easy manipulation of MIR, NIR and Raman imaging and mapping data files from a variety of vendors, ISys includes all […]

Bloomfield brings broad-based experience in commercial leadership roles with global corporations and proven business skills Strasbourg — Polyplus-transfection SA, the privately-held company developing innovative solutions for molecular and cellular biology, today announced that its board has appointed Mark Bloomfield as CEO. Mark Bloomfield replaces Frédéric Perraud who continues with Polyplus as COO and Deputy CEO. […]

PENZBERG, Germany–Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents. Viability and cytotoxicity assays are routinely […]

Non-Animal Recombinant Proteins for Cell Culture & Tissue Engineering Applications AMSBIO has announced a new range of recombinant proteins that can substitute extracellular matrix proteins that are currently extracted from mouse sarcoma. The Mussel Adhesive Protein based matrix (MAPTrix®) ECM line of products are coating reagents with genetically incorporated bioactive peptides which mimic the extracellular […]